ROSSARI — Rossari Biotech Balance Sheet
0.000.00%
- IN₹38.23bn
- IN₹39.00bn
- IN₹18.31bn
- 66
- 14
- 18
- 20
Annual balance sheet for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,461 | 890 | 640 | 1,503 | 708 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,076 | 1,612 | 3,263 | 3,676 | 4,625 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,263 | 3,547 | 6,093 | 7,214 | 8,448 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,105 | 1,682 | 3,480 | 3,267 | 3,619 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,715 | 5,613 | 12,567 | 13,676 | 15,722 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,487 | 1,502 | 2,947 | 3,485 | 4,247 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,848 | 1,526 | 4,516 | 4,524 | 5,244 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2,867 | 4,088 | 8,052 | 9,152 | 10,477 |
Total Liabilities & Shareholders' Equity | 4,715 | 5,613 | 12,567 | 13,676 | 15,722 |
Total Common Shares Outstanding |